How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?
Laverty H, Benson C, Cartwright E, Cross M, Garland C, Hammond T, Holloway C, McMahon N, Milligan J, Park B, Pirmohamed M, Pollard C, Radford J, Roome N, Sager P, Singh S, Suter T, Suter W, Trafford A, Volders P, Wallis R, Weaver R, York M, Valentin J.
Laverty H, et al. Among authors: wallis r.
Br J Pharmacol. 2011 Jun;163(4):675-93. doi: 10.1111/j.1476-5381.2011.01255.x.
Br J Pharmacol. 2011.
PMID: 21306581
Free PMC article.
Review.